Knowing where all our ingredients come from is the first step toward improving drug quality.

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

Drug makers aren't chasing blockbusters like Lipitor anymore, or uncovering compounds the same way.

The FDA must continue to pressure Chinese authorities to test what is on the market and remove any substandard products found.

Two decades ago, European firms dominated the world pharmaceutical market, just as they had for most of the twentieth century. Now, with a few notable exceptions, the market is dominated by American firms. U.S.-based companies account for most of the worldwide bestselling drugs and for most newly introduced breakthrough drugs--especially...

This paper reviews a large literature on the effects of pharmaceutical industry price controls on the organization and practices of firms.

Developing new, effective drugs is staggeringly expensive, and the high prices of certain drugs on the market are directly related to this initial investment, according to a new AEI Press book.